18 /100
LOW RISK
Score updated May 28, 2026

ACRS — Aclaris Therapeutics, Inc. Dilution Risk Tracker

Track ACRS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ACRS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 8 points (worsening)
🔔 Track ACRS — Get forecast alerts →

💹 Market Data

Market Cap$641.06M
Shares Outstanding139.66M
Float113.21M
Cash$28.66M
Debt$10.73M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.1% shares (2025Q4 vs prior)
121 institutional holders · 87.63M shares
#1 BML Capital Management, LLC 14.25M shares
#2 Vivo Capital, LLC 8.89M shares
#3 BlackRock, Inc. 6.80M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.89M
Days to Cover5.3
% of Float7.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Apr 27, 2026
8-K 8K EVENT Mar 11, 2026
8-K 8K EVENT Mar 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ACRS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ACRS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ACRS
📊 ACRS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ACRS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.